Retained Earnings (Accumulated Deficit) of REGENEREX PHARMA, INC. from 20 May 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
REGENEREX PHARMA, INC. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 20 May 2010 to 30 Sep 2025.
  • REGENEREX PHARMA, INC. Retained Earnings (Accumulated Deficit) for the quarter ending 30 Sep 2025 was $9,620,486, a 50% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

REGENEREX PHARMA, INC. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $9,620,486 -$3,202,504 -50% 30 Sep 2025 10-Q 17 Nov 2025 2025 Q2
Q2 2025 $8,806,475 -$2,918,065 -50% 30 Jun 2025 10-Q 14 Aug 2025 2024 Q1
Q1 2025 $8,142,891 -$2,527,041 -45% 31 Mar 2025 10-Q 17 Nov 2025 2025 Q2
Q4 2024 $6,732,506 -$1,409,483 -26% 31 Dec 2024 10-Q 07 Feb 2025 2024 Q3
Q3 2024 $6,417,982 -$1,358,935 -27% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q2
Q2 2024 $5,888,410 -$3,630,812 -161% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q1
Q1 2024 $5,615,850 -$3,543,827 -171% 31 Mar 2024 10-K 30 Jun 2025 2024 FY
Q4 2023 $5,323,023 -$3,297,290 -163% 31 Dec 2023 10-Q 05 Feb 2024 2023 Q3
Q3 2023 $5,059,047 -$3,082,714 -156% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q2
Q2 2023 $2,257,598 -$299,701 -15% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q1
Q1 2023 $2,072,023 -$137,330 -7.1% 31 Mar 2023 10-K 24 Jun 2024 2023 FY
Q4 2022 $2,025,733 -$139,489 -7.4% 31 Dec 2022 10-Q 24 Jan 2023 2022 Q3
Q3 2022 $1,976,333 -$169,523 -9.4% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q2
Q2 2022 $1,957,897 -$184,843 -10% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q1
Q1 2022 $1,934,693 -$195,591 -11% 31 Mar 2022 10-K 09 Jun 2023 2023 FY
Q4 2021 $1,886,244 -$431,622 -30% 31 Dec 2021 10-Q/A 03 Feb 2022 2021 Q3
Q3 2021 $1,806,810 -$385,871 -27% 30 Sep 2021 10-Q 01 Nov 2021 2021 Q2
Q2 2021 $1,773,054 -$377,887 -27% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q1
Q1 2021 $1,739,102 -$353,752 -26% 31 Mar 2021 10-Q/A 03 Feb 2022 2021 Q3
Q4 2020 $1,454,622 -$109,568 -8.1% 31 Dec 2020 10-Q 11 Feb 2021 2020 Q3
Q3 2020 $1,420,939 -$96,438 -7.3% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q2
Q2 2020 $1,395,167 -$89,137 -6.8% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q1
Q1 2020 $1,385,350 -$111,589 -8.8% 31 Mar 2020 10-K 23 Jun 2021 2020 FY
Q4 2019 $1,345,054 -$87,745 -7% 31 Dec 2019 10-Q 10 Feb 2020 2019 Q3
Q3 2019 $1,324,501 -$120,937 -10% 30 Sep 2019 10-Q 30 Oct 2019 2019 Q2
Q2 2019 $1,306,030 -$107,275 -8.9% 30 Jun 2019 10-Q/A 29 Jul 2019 2019 Q1
Q1 2019 $1,273,761 -$93,579 -7.9% 31 Mar 2019 10-K/A 11 Aug 2020 2019 FY
Q4 2018 $1,257,309 -$91,127 -7.8% 31 Dec 2018 10-Q 04 Feb 2019 2018 Q3
Q3 2018 $1,203,564 -$47,823 -4.1% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q2
Q2 2018 $1,198,755 -$51,141 -4.5% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q1
Q1 2018 $1,180,182 -$49,671 -4.4% 31 Mar 2018 10-K 24 Jun 2019 2018 FY
Q4 2017 $1,166,182 31 Dec 2017 10-Q 08 Feb 2018 2017 Q3
Q3 2017 $1,155,741 30 Sep 2017 10-Q 07 Nov 2017 2017 Q2
Q2 2017 $1,147,614 30 Jun 2017 10-Q 07 Aug 2017 2017 Q1
Q1 2017 $1,130,511 31 Mar 2017 10-K 21 Jun 2018 2017 FY
Q4 2014 $105,837 $0 0% 30 Nov 2014 10-K 03 Mar 2015 2014 FY
Q3 2014 $105,837 31 Aug 2014 10-Q 20 Oct 2014 2014 Q3
Q2 2014 $105,837 31 May 2014 10-Q 23 Jul 2014 2014 Q2
Q1 2014 $105,837 28 Feb 2014 10-Q 11 Apr 2014 2014 Q1
Q4 2013 $105,837 $0 0% 30 Nov 2013 10-K 03 Mar 2015 2014 FY
Q4 2012 $105,837 $0 0% 30 Nov 2012 10-K 28 Feb 2014 2013 FY
Q3 2012 $105,837 $0 0% 31 Aug 2012 10-Q 15 Oct 2012 2012 Q3
Q2 2012 $105,837 31 May 2012 10-Q 16 Jul 2012 2012 Q2
Q4 2011 $105,837 $0 0% 30 Nov 2011 10-K/A 28 Feb 2013 2012 FY
Q3 2011 $105,837 31 Aug 2011 10-Q 13 Oct 2011 2011 Q3
Q4 2010 $105,837 30 Nov 2010 10-K 28 Feb 2012 2011 FY
Q2 2010 $104,000 20 May 2010 10-K 03 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.